Evidence map›Paper›PMID 40841155›Full record

ArticleTobacco control2025

Cigarette and cigarillo ads promote 'flavour' in a US state that prohibits flavoured tobacco sales.

Trent O Johnson, Nora Satybaldiyeva, Nina C Schleicher, Mary Hrywna, Lisa Henriksen

Abstract read
In one paragraph

Article in Tobacco control, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Trent O JohnsonDepartment of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, California, USA trentj@stanford.edu.ORCID http://orcid.org/0000-0001-7022-0242
Nora SatybaldiyevaDepartment of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, California, USA.ORCID http://orcid.org/0000-0003-3774-791X
Nina C SchleicherDepartment of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, California, USA.ORCID http://orcid.org/0000-0002-6076-5713
Mary HrywnaRutgers Institute for Nicotine & Tobacco Studies, New Brunswick, New Jersey, USA.ORCID http://orcid.org/0000-0002-0717-9598
Lisa HenriksenDepartment of Medicine, Stanford Prevention Research Center, Stanford University School of Medicine, Palo Alto, California, USA.ORCID http://orcid.org/0000-0002-9288-3562

Funding

Rutgers Center of Excellence in Rapid Surveillance of TobaccoU01CA278695 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI CRISTINE D DELNEVO, Ollie Ganz · 2023 to 2026
$14.0M
Project 3: Tobacco Town Policy ModelingP01CA225597 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HENRIKSEN, LISA ANNE, LUKE, DOUGLAS A · 2018 to 2023
$11.5M
Cardiovascular and Chronic Disease Prevention Training ProgramT32HL161270 · NHLBI · STANFORD UNIVERSITY · PI CHRISTOPHER D GARDNER · 2022 to 2026
$2.6M
NCI NIH HHS P01 CA225597NCI NIH HHS U01 CA278695NHLBI NIH HHS T32 HL161270
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Advertising and PromotionPriority/special populationsPublic policyTobacco industry

Identifiers

PMID40841155
PMCPMC12479047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.